Advertisement

Topics

Collateral Therapeutics Incorporated Company Profile

03:38 EDT 26th September 2017 | BioPortfolio

Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blood vessels, to increase levels of blood flow to oxygen-deprived tissues.

The Company's angiogenic products are administered using methods of gene therapy based on non-surgical adenoviral vector delivery of angiogenic genes. In addition to the Company's angiogenic product candidates, the Company is actively researching gene therapy products designed to increase responsiveness of the heart to adrenergic stimulation and to stimulate heart muscle regeneration.



The Company's lead product candidate, GENERX™ (Ad5-FGF4) is a non-surgical angiogenic gene therapy, which is being developed as a potential treatment for patients with stable exertional angina (chest pain) due to coronary artery disease (CAD).

Location

11622 El Camino Real
San Diego
ca
92130
United States of America

Contact

Phone: 858.794.3400
Fax: 858.794.3440
Email: info@collateralthx.com


News Articles [1544 Associated News Articles listed on BioPortfolio]

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Summit Therapeutics PLC (SMMT) and Orexigen Therapeutics (OREX) Head to Head Review

Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

Pulmonx, Inc. Release: New Data From Two Multi-Center Randomized Clinical Trials Demonstrate That Zephyr Endobronchial Valves Deliver Benefit To Both Heterogeneous And Homogenous Emphysema Patients Without Collateral Ventilation

  Life Sciences Jobs   ...

Hypoactive delirium

What you need to knowHypoactive presentations of delirium are more common than the classically agitated, hyperactive forms and may be overlookedA collateral history can distinguish hypoactive...

3DIcon Develops New Market Collateral

Coretec HexaSilane™ Technical Datasheet and Li-Ion Battery, Electronics and Solar Market Sell Sheets Developed TULSA, OK--(Marketwired - June 21, 2017) -In conjunction with Read more...

PubMed Articles [659 Associated PubMed Articles listed on BioPortfolio]

Stroke etiology and collaterals: atheroembolic strokes have greater collateral recruitment than cardioembolic strokes.

Chronic hypoperfusion from athero-stenotic lesions is thought to lead to better collateral recruitment compared to cardioembolic strokes. It was sought to compare collateral flow in stroke patients wi...

The effectiveness of super-selective injection with anchor balloon technique for collateral channel assessment.

The careful assessment of collateral channels is important for a retrograde approach for a chronic total coronary occlusion (CTO). This case report describes a percutaneous coronary intervention for C...

Clinical significance of mesenteric arterial collateral circulation in patients with celiac artery compression syndrome.

Although extensive collateral arterial circulation will prevent ischemia in most patients with stenosis of a single mesenteric artery, mesenteric ischemia may occur in these patients, for example, in ...

Collateral artery pathways of the femoral and popliteal artery.

The role of collateral artery circulation in the lower limb is under debate but clinically relevant, particularly when using covered stents for occlusive disease. Covered stents seem to outperform nit...

Simultaneous Reconstruction of the Medial and Lateral Collateral Ligaments for Chronic Combined Ligament Injuries of the Ankle.

Objective data on chronic injuries of the medial collateral ligament (MCL) of the ankle are scarce. Chronic MCL injuries are frequently associated with lateral collateral ligament (LCL) injuries. For ...

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

Comparison of Coronary Wedge Pressure and Collateral Flow Index Between Main Branch and Side Branch Vessels

The purpose of this trial is to compare the degree of collateral flow in the main vessel and the side branch vessel. Specifically, the trial will address the superiority of the recruitable...

the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population

This study observed the relationship between cerebral collateral circulation and the prognosis of leukoaraiosis in high-risk population. Cerebral collateral circulation and leukoaraiosis l...

The Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion

Stroke is the first leading cause of death in China, and is responsible for almost 22.4% of deaths. In approximately 80% of cases stroke is ischaemic, i.e. caused by disruption of blood fl...

MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

Based on the results of recent randomized controlled trials, current international guidelines recommend the initiation of endovascular treatment within 6 hours of symptom onset for acute i...

Ultrasound Study of Season-Long Joint Changes to College Baseball Players

The purpose of this study is to use ultrasound imaging to determine if there are certain frequencies, durations, and intensities of baseball pitching that expose a college baseball player ...

Companies [1198 Associated Companies listed on BioPortfolio]

Collateral Therapeutics Incorporated

Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance angiogenesis, a natural biological process which results in the growth of additional blo...

Cardium Therapeutics, Inc.

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sal...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

ADVANCE Recruitment

More means doing WHATEVER it takes to make our clients' recruitment efforts a success. It means sitting down with our clients, assessing their unique staffing needs and then prescribing a comprehensiv...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Collateral Therapeutics Incorporated" on BioPortfolio

We have published hundreds of Collateral Therapeutics Incorporated news stories on BioPortfolio along with dozens of Collateral Therapeutics Incorporated Clinical Trials and PubMed Articles about Collateral Therapeutics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Collateral Therapeutics Incorporated Companies in our database. You can also find out about relevant Collateral Therapeutics Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record